The Pentagon said Wednesday that a US civilian contractor died of a "cardiac episode" while taking shelter during the rocket attack.
Market ScenarioSupraventricular tachycardia is a condition where there is a rapid increase in the heart rate that is caused by electrical impulses originating above the heart.Paroxysmal supraventricular tachycardia, also known as PSVT, is a condition wherein the patient shows an irregularity in heart beating.A normal heart beats between 60 to 100 beats per minute, but the heart rate of a person suffering from paroxysmal supraventricular tachycardia during an episode may exceed 150–200 beats per minute.The prevalence of Paroxysmal Supraventricular Tachycardia (PSVT) is unknown but is projected to be around several cases per thousand persons.Moreover, some arrhythmias may lead to more serious medical problems such as sudden stroke or cardiac arrest.The global Paroxysmal Supraventricular Tachycardia (PSVT) market is expected to register a CAGR of approximately 6.50% during the forecast period, 2017–2023.SegmentationThe global Paroxysmal Supraventricular Tachycardia (PSVT) market is segmented on the basis of type, diagnosis, treatment, and end-user.On the basis of type, the global Paroxysmal Supraventricular Tachycardia (PSVT) market is segmented into AV Nodal Re-Entrant Tachycardia (AVNRT), AV Reciprocating Tachycardia (AVRT), Paroxysmal Atrial Tachycardia (PAT), and Wolff-Parkinson-White Syndrome (WPW).On the basis of diagnosis, the Global Paroxysmal Supraventricular Tachycardia (PSVT) market is classified into Electrophysiology Study (EPS), stress test, cardiac catheterization, coronary angiography, Electrocardiogram (ECG), echocardiogram, Holter monitor, event monitor, implantable monitor, lab tests, and others.Lab tests are further classified into blood test, urine test, and others.On the basis of treatment, the global Paroxysmal Supraventricular Tachycardia (PSVT) market is classified into physical maneuvers, medications, catheter ablation, pacemaker, and cardioversion.The antiarrhythmic medication is divided into sotalol, amiodarone, amiodarone, flecainide, propafenone, and adenosine.On the basis of end-user, the global Paroxysmal Supraventricular Tachycardia (PSVT) market is classified into hospitals and clinics, diagnostic centers, medical research centers, and others.Regional AnalysisThe global Paroxysmal Supraventricular Tachycardia (PSVT) market consists of four major regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.The Americas dominates the market owing to the key players domiciled in these regions coupled with the increasing incidences of stroke, raising awareness among people, and increasing healthcare expenditure.
Mar 03, 2021: The Global Coronary Stent Market is predicted to reach USD 15.18 billion by 2024 owing to factors include technological advancements, rising load of CAD, growing number of PCI procedures (percutaneous coronary intervention), increasing geriatric population and increasing demand for user-friendly procedures.This helps the artery to open and stabilize the blood flow to the heart.The Coronary stents are used in the treatment of cardiac disorders like angina pain, myocardial infarction and coronary artery disease.The Coronary Stent Market is expected to grow significantly with CAGR of 6.2% in the forecast period.Download sample Copy of This Report at: Coronary Stent prevents the heart attack that is caused by the narrowing of coronary arteries.The stent is made of cobalt alloy or stainless steel tube and is attached to small balloons that support to proper blood flow and take care of the vessel wall.Owing to the rising elderly population across globe, particularly in the developed economies, the market expects wide opportunities in the different parts of the world.
The report appears out as an intelligent and thorough assessment tool as well as a great resource that will help you to secure a position of strength in the global Ventricular Assistance Devices.It includes Porter’s Five Forces and PESTLE analysis to equip your business with critical information and comparative data about the Global Ventricular Assistance Devices.Our analysts use the most advanced original and subordinate research techniques and tools to prepare full and accurate market research reports.To Remain 'Ahead' of Your Competitors, Request For A PDF Sample @ report provides insights on the following pointers:Market Penetration: Complete information on the product portfolios of the top players in the Ventricular Assistance Devices market.Product Development/Innovation: Detailed insights on the upcoming technologies, R activities, and product launches in the market.Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.Market Development: Comprehensive information about emerging markets.This report analyzes the market for various segments across geographies.Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Ventricular Assistance Devices market.Download the Post-Pandemic Business Planning Structure @ Assistance Devices: Analyst ViewThe research work provides a concrete market definition along with a detailed structure of industry which helps readers gain a holistic understanding of the Ventricular Assistance Devices.A detailed assessment of the market supply chain analysis, business execution, and value chain analysis across regional markets has been provided in the report.The major players who are leading the market throughout the globe are Abiomed, Berlin Heart, Cardiac Assist, HeartWare, Jarvik Heart, Reliant Heart, St. Jude Medical, Sun Medical, Syncardia System, Thoratec.Apart from the extensive details of the Ventricular Assistance Devices, ensure to include sections that give you opinion straight from the global industry experts.Report HighlightsComprehensive pricing analysis on the basis of product, application, and regional segmentsThe detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the global Ventricular Assistance DevicesDeep insights about regulatory and investment scenarios of the global Ventricular Assistance DevicesAnalysis of market effect factors and their impact on the forecast and outlook of the global Ventricular Assistance DevicesA roadmap of growth opportunities available in the global Ventricular Assistance Devices with the identification of key factorsThe exhaustive analysis of various trends of the global Ventricular Assistance Devices to help identify market developmentsBrowse More Market Report From MarketwatchSection 01 – Ventricular Assistance Devices Executive SummaryThe report begins with the succinct executive summary of the Ventricular Assistance Devices, which is the first chapter, includes a summary of the statistics of the market.
Global Sinus Irrigation Systems Market: IntroductionSinuses are hollow cavities and connected systems present in the human skull.The cheekbones hold the maxillary sinus, which is the largest sinus.Request a PDF Brochure - Sinus Irrigation Systems Market: Competition LandscapeKey players operating in the global sinus irrigation systems market are Medtronic Plc., Neilmed Pharmaceuticals Inc., Medstar Co. Ltd., Air Liquide Medical Systems, Sinh2ox Health & Care, Heal Force, Bremed Ltd., WelbuTech, CHAMMED, and RhinoSystem, Inc.Medtronic operates through four business segments: cardiac & vascular group, diabetes group, restorative therapies, and minimally invasive therapies.Through these segments, the company caters to hospitals, physicians, clinicians, and patients in approximately 160 countries.Moreover, the existing market players are deploying advanced techniques to develop new processes for the development of technologically advanced sinus irrigation systems.
03rd Mar 2021 - With reference to the report circulated by the professionals the scope of the global Fractional Flow Reserve Market was priced at US$ 549.7 million in 2018 and is projected to touch US$ 1.20 billion by 2026.It is estimated to display a CAGR of 10.4% for the duration of the forecast.Fractional flow reserve (FFR) is a guidewire centered procedure that has the capability to exactly count the pressure of the blood and the movement over a certain slice of the coronary artery.During the period of1990s, the fractional flow reserve was developed and is utilized in coronary catheterization.The capacities of fractional flow reserve has been found beneficial in assessing whether to do stenting or else angioplasty on intermediate obstructions.Access Fractional Flow Reserve Market Report with TOC @ increase in the circumstances of cardiac illnesses for example high blood pressure and coronary artery illnesses are the most important reasons in the progress of the fractional flow reserve industry.As stated by the American College of Cardiology (ACC) in 2017, around 31.0% of total deaths through the world were instigated by cardiac illnesses.Speedily increasing elderly people, increasing occurrence of type 2 diabetes and cardiac complaints similar to high blood pressure and coronary artery illnesses, increasing price benefits of fractional flow reserve, growing funds for R activities by most important companies, availability of advantageous compensation strategies, speeding up number of monitoring supports in addition to clinical trials.Also increasing necessity for the technology of fractional flow reserve are majorly motivating the development of the global market.
Mycoplasma testing market is expected to gain market growth in the forecast period of 2020 to 2027.Data Bridge Market Research analyses the market to account USD 1,704.58 million by 2027 growing at a CAGR of 12.56% in the above-mentioned forecast period.This mycoplasma testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size.Download exclusive PDF sample [email protected] Mycoplasma Testing Market Scope and Market SizeBased on technique, the mycoplasma testing market is segmented into PCR, ELISA, direct assays, indirect assays, DNA staining, microbial culture techniques and enzymatic methods.On the basis of product, the mycoplasma testing market is segmented into kits & reagents, instruments and others.Kits and reagents are further segmented into PCR assays, nucleic acid detection kits, elimination kits & reagents, stains, standards & controls and others.Based on the application, the mycoplasma testing market is segmented into cell line testing, virus testing, end-of-production cell testing and otherOn the basis of end users, the mycoplasma testing market is segmented into hospitals and surgical centers, oncology centers, clinics, community healthcare and others.Based on distribution channel, the mycoplasma testing market is segmented into retail and direct tenders.Key Players: Global Mycoplasma Testing MarketThe major players covered in the mycoplasma testing market report are Medtronic, Biosense Webster, Inc, Abbott, Boston Scientific Corporation, AngioDynamics, AtriCure, Inc., CONMED Corporation, Olympus Corporation, Smith & Nephew, Advanced Cardiac Therapeutics, MedlinePlus, CardioFocus, Medtronic, Estech, Auris Health, Inc., Imricor, Japan Lifeline Co., Ltd.,, ARTWORKSIT, MicroPort Scientific Corporation, Spectranetics, Stereotaxis, Inc. and among other domestic and global players.Focus of the reportCAGR values in the market for the forecast periodKey trends in the market placeMajor players and brandsHistorical and current market size and projection up to 2026.Detailed overview of parent marketChanging market dynamics of the industryReasons to Purchase this ReportThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersInquiry Before Buying @ insights in the report:Complete and distinct analysis of the market drivers and restraintsKey Market players involved in this industryDetailed analysis of the Market SegmentationCompetitive analysis of the key players involvedAbout Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.Contact:Data Bridge Market ResearchUS: +1 888 387 2818   Related Reports:Operational room management MarketNanorobots Market
Market Research Future published a half cooked research report on “Global Advanced Cardiovascular Life Support Market Research Report – Forecast to 2024– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2024.CPR Medical Devices, Inc. (Canada), Cardiac Science Corporation (US), General Electric Company (US), Koninklijke Philips N.V. (Netherlands), Michigan Instruments (US), Physio-Control, Inc. (US), St. Jude Medical, Inc. (US), Asahi Kasei Corporation (Japan) and others are some of the major players in the Global Advanced Cardiovascular Life Support Market.Request For Free Sample Copy : Advanced Cardiovascular Life Support Market – OverviewAdvanced cardiovascular life support is also referred as advanced cardiac life support is a set of clinical interventions for the emergency treatment of stroke and other life-threatening medical emergencies.Other factors that propel the growth of market are continuous up gradation and modification of products, rising diabetic and obese population and excessive use of tobacco and alcohol.However, limited number of trained personnel has restrained of the growth of market.Further The prevalence of cardiovascular diseases across the globe is continuously increasing owing to rising geriatric population, increasing diabetic population, and changing the lifestyle of the people.According to the International Monetary Fund (IMF), The U.S. economy grew in 2016 by 1.6% in 2016.Furthermore, in 2016, healthcare organizations found liberation from a special tax on medical devices (Medical Device Excise Tax Act, 2013).Healthcare spending has expanded slightly in U.K and Germany.Western Europe continues to see a need to save money on healthcare because of a slight drop in financial growth and obstinate economic pressure.
There are various wings of the hospital like - Neuro - neuropsychological; Cardiovascular; orthopedic; umatology; ENT; infectious diseases etc.As it has dedicated care facilities for special needs, it is considered one of the finest facilities of its kind.Some of the special care facilities offered by the hospital include - Cardiac Care, Critical Care, Neonatal and neonatal care, Surgical, Acute care, psychiatric care, pain management, surgery, psychotherapy etc.The hospital is fully equipped to take care of the special needs of infants and small children.The pediatric department is fully taken care of, along with special care units for children who have special needs like autism, cerebral palsy, Fragile X Syndrome, Down syndrome etc.The hospital also has specialty departments dealing with renal care, cardiac care, neonatology, oncology, pulmonology, radiology, gastroenterology, abdominal and thoracic surgical, ENT, neurological, plastic surgery, plastic and reconstructive surgery, critical care, cardiology, oncology, gastroenterology, traumatology, refractory care, gastroenteropsychology, pediatrics etc.
  Market Research Future published a Half Cooked research report on “Middle East & Africa Paediatric Healthcare Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.Paediatric Healthcare-OverviewPaediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group.It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years).Malnutrition among children prevalent in under developed parts of the world is also a major driver of this market.The main focus of these players is tapping the market in developing regions across the globe.Roche will pay GeneWEAVE shareholders USD 190 million upfront and up to USD 235 million in contingent product related milestonesFebruary 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient TestingSeptember 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancyMedtronic plc.:October, 2016: Medtronic plc received an approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI) machines.
The global Microelectronic Medical Implants Market is expected to grow at a CAGR of 9.1% over the forecast period of 2018-2022, reveals a research report published by Market Research Future (MRFR).The market has observed rapid growth on account of rising prevalence of cardiac disorders such as cardiac arrest, heart failure, artery diseases, stroke.Such cardiac diseases accelerate the demand for medical implants such as Pacemakers, Defibrillators, and Neurostimulators which positively impact the market growth.Improvements have led to the development of novel smart implants which have the ability to transmit and capture data and can be equipped with sensors and cameras.Other driving factors include increased expenditure on medical facilities, rising government support and investment from crucial players on R activities which leads to innovation of novel products.FDA imposes stringent regulations on approval of such devices which makes clearance a tedious and lengthy process and is a key hindrance to the growth of the market.Other restraining factors include high costs associated with them and failure of such medical implants.
Laparoscopic surgical robotic devices market is an increment in the fraction of victims bearing health problems of obesity, Crohn's diseases, ulcerative colitis, diverticulitis, and gall bladder difficulty are some determinants encouraging the trade of laparoscopic surgical robotic devices.Laparoscopy is a kind of operational method that permits a specialist or doctor to locate the interior of the belly and pelvis by forming a hole through exteriors of the stomach or body.The market visionaries anticipate that the global demand to expand laparoscopic robotics is owing to booming utilization of laparoscopy-based robotic resolutions in cardiac, gynaecological, ear/nose/throat (ENT), urological, and gastrointestinal operation.High-priced aid of the laparoscopic surgical robotic devices will be fewer of the limitations pulling back the market germination.Whereas considering the type of operation to be carried out by robotics aid is for the extremely crucial parts of the body on the agreement of life-expectancy which yields the greatest possibility of surgical robots in ambulatory surgery centers.Laparoscopic surgical robotic devices market is expected to gain market growth in the forecast period of 2020 to 2027.The spreading consciousness amidst the doctors and sufferers concerning the advantages linked with the practice of surgical robotics in laparoscopy has held a direct impact on the germination of laparoscopic operational robotic devices market..This Laparoscopic Surgical Robotic Devices Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.
Ultrasound transducers are systems used to evaluate targets and interpret the reflected signals.However, new developments in ultrasound technology and cardiac ultrasounds allow imaging at the cellular or molecular level, paving the way for earlier diagnosis and treatment of diseases.Request a PDF Brochure - prevalence of diseases such as cardiovascular diseases, geriatric population with bypass surgery, rising patient awareness programs, growing research and development initiatives for heart diseases, and increasing demand for diagnostic imaging devices are the major factors driving the cardiac ultrasound transducers market.According to the WHO, cardiovascular disease is one of the leading cause of death globally.In 2016, WHO reported 16 million deaths under the age of 70 years which is due to non-communicable diseases, and 37% death were caused by cardiovascular diseases.Cardiovascular is a rapidly growing application segment because of increasing prevalence of cardiovascular diseases globally.In terms of end-user, the cardiac ultrasound transducers market has been classified into diagnostic laboratories, ambulatory surgical units, hospitals, clinics, and others.
Rapid infuser is a procedure/treatment which involves administration of rapid fluid used during surgical procedure.There are two prominent types of rapid infuser devices: one is driven by compressor, while the other is connected to hospital wall pressurized outlets.Request a PDF Brochure - and most effective way of delivering fluids in short span of time are the major factors deriving the global market.Moreover, use of this device in anesthesia centers have evolved over the years owing to product enhancements and application of information and sensing technology.According to new estimates by the World Health Organization, COPD is predicted to become the third leading cause of death by 2030.According to the Centers for Disease Control and Prevention (CDC), approximately 51.4 million surgical procedures were performed in the U.S. alone in 2010, which included 1.01 million cardiac catheterizations, 1.1 million endoscopic procedures of the small intestine (with or without biopsy), 499,000 endoscopic procedures of the large intestine (with or without biopsy), 395,000 coronary artery bypass grafts (CABG), 719,000 knee replacements, and 332,000 total hip replacements.It has also revealed that the number would increase in the near future.
The Global Non-Invasive Monitoring Device Market is expected to register a CAGR of 6.80% and is anticipated to reach USD 21,586.2 Million by 2023.Non-invasive monitors do not require rupturing of skin and penetration of any device into the body of the patient.Non-invasive monitors have sensors attached which play an essential role in generating readings of the body vitals.Browse Sample of the Report @ increasing prevalence of cardiovascular diseases, increasing adoption of non-invasive technology, increasing prevalence of neurovascular diseases, increasing geriatric population, and favorable reimbursement policies are the major drivers propelling market growth.However, the erroneous readings and stringent regulatory norms constrain the growth of the market.Market DynamicsAccording to a report published in 2015 by the Center for Disease Control and Prevention (CDC), every year, more than 630,000 Americans die from heart diseases.Moreover, according to a report published by the CDC, in 2017, nearly 30.3 million people have diabetes only in the US.By type, the market has been segmented into cardiac monitoring devices (electrocardiography and cardiac output monitors), brain monitoring devices, blood pressure monitoring devices, anesthesia monitoring devices, and blood glucose monitoring devices.
Market Database states that magnetic resonance imaging (MRI) compatible pacemakers have experienced a larger share in the market.Global Market Database can be used to recognize other drivers associated with the medical equipment market.According to the market database procured via Mayo Foundation for Medical Education and Research in 2018, approximately 75% of patients who possessed pacemakers are expected to undergo MRI scans at least once in their lifetime.These are non-invasive and offer a low risk of post-surgical complications.The value chain for this market can be studied through Global Market Database.This includes hospitals, dedicated cardiac centers, and ambulatory surgical centers.Factors such as lifestyle disorders, excessive alcohol consumption, smoking, and obesity have contributed to cardiac arrhythmia.According to the market database, published by the Centers for Disease Control and Prevention (CDC) in 2017, Atrial fibrillation was the most common form of arrhythmia.
The Cardiology Defibrillators Devices market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.The research report provides analysis and information according to Cardiology Defibrillators Devices market segments such as geography, product type & applications.The Cardiology Defibrillators Devices market research report has combined the analysis of different factors that augment the market’s growth.The report also provides the scope of different segments and applications that can potentially influence the Cardiology Defibrillators Devices market in the future.The primary objective of the Cardiology Defibrillators Devices market report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with Cardiology Defibrillators Devices.This report also provides an estimation of the Cardiology Defibrillators Devices market size and corresponding revenue forecasts carried out in terms of US$.It also offers actionable insights based on the future trends in the Cardiology Defibrillators Devices market.Furthermore, new and emerging players in the global Cardiology Defibrillators Devices market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global Cardiology Defibrillators Devices market.Request a Sample Report of Cardiology Defibrillators Devices Market: Companies Covered in this Report:Biotronik, Boston Scientific Corporation, Cardiac Science Corporation, Heartsine Technologies, Medtronic, Nihon Kohden, Philips Healthcare; Heartstream Division, Physio-Control, ST.Jude Medical, Sorin GroupZoll Medical, Cardiac Science, Laerdal Medical Corporation, Medical Research Laboratories, Medtronic Physio-Control Corporation, DefibtechBy Types:Implantable Cardioverter Defibrillator (ICDs)External DefibrillatorWearable Cardioverter Defibrillator (WCDs)By Applications:HospitalsInstitutesOthersQuantifiable data:• Market Data Breakdown by Key Geography, Type & Application / End-User• By type (past and forecast)• Cardiology Defibrillators Devices Market-Specific Applications Sales and Growth Rates (Historical & Forecast)• Cardiology Defibrillators Devices revenue and growth rate by market (history and forecast)• Cardiology Defibrillators Devices market size and growth rate, application and type (past and forecast)• Sales revenue, volume and Y-O-Y growth rate (base year) of Cardiology Defibrillators Devices marketIf Your Have Any Questions About This Report, Please Reach Out to Us: separate section of covid-19 crisis which consists:Description: This section sums up entire research study along with volume forecasts and CAGR value.Major Segments: This segment provide information about leading segments with important factors like growth potential and share.Leading Regions: In depth study of major regions in covid-19 pandemic and countries overall growth during this crisis.Competitors profiling: Accurate study of competitive landscape in affected regions and other studies.Dynamics: Aspects such as market constraints, prospective supply and demand, barriers, opportunities, etc.
Factors such as the rising geriatric population, large and established medical technology industry, increasing number of surgical procedures, growing need for cost-containment in the healthcare industry, and the availability of funding for research and product innovation are driving the growth of this market.However, fiscal unsustainability due to wasteful spending might hamper the market growth to a certain extent.The base year considered for the study is 2019, while the forecast period is 2020 to 2025.The report European Medical Devices Market  is projected to reach USD 61.4 billion by 2025 from an estimated USD 48.9 billion in 2020, at a CAGR of 4.7% during the forecast period.Ask for PDF Brochure: - Segmentation: -By device, orthopedic devices segment accounted for the largest share of the European Medical Device Market in 2019Based on device type, the market has been segmented into orthopedic devices, diagnostic imaging systems, endoscopy devices, ophthalmic devices, interventional cardiology devices, cardiac monitoring and cardiac rhythm management devices, respiratory care devices, ventilators, anesthesia monitoring devices, dialysis devices, and diabetic care devices.The orthopedic devices segment accounted for the largest share of the European medical devices market in 2019.The growing incidence of orthopedic disorders such as arthritis, osteoporosis, soft-tissue injuries, and fractures among the elderly population is expected to drive the demand for orthopedic devices in Europe.The Hospitals and clinical care settings segment is expected to witness the highest growth rate in the European medical devices market, by end-user, during the forecast periodBased on end-user, the European medical devices market is segmented into hospitals and clinical care settings and home care settings.Hospitals and clinical care settings were the largest end-users of medical devices in Europe in 2019.
According to research report the pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0% during the forecast period.Download PDF Brochure: pacemaker is a medical device used when the heart is unable to produce electrical impulses naturally.When the heart’s natural pacemaker is defective or when the electrical pathways of the heart are blocked, it can cause irregular heartbeats, as known as arrhythmias.A pacemaker uses electrical pulses to prompt the heart to beat at a normal rate to treat arrhythmias.Recent Developments:• In November 2017, Medtronic received FDA approval and launched the Azure pacemaker with BlueSync technology in the US market• In February 2017, Medtronic received CE Mark certification for its Next Generation Cardiac Resynchronization Therapy-Pacemakers• In February 2017, Abbott Laboratories received FDA approval for the Assurity MRI Pacemakers• In March 2016, St. Jude Medical received the CE Mark certification for MRI compatibility for its Nanostim leadless pacemakersThe major players in the pacemakers market include Medtronic (Ireland), Abbott (US), and Boston Scientific (US) BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China).These players have adopted various growth strategies such as expansions, acquisitions, and new product launches to expand their presence in the global pacemakers market.This has helped them to expand their consumer base and address the unmet needs of end users.In line with rising adoption of pacemaker devices, Medtronic focus on to develop innovative products for the treatment of heart rhythm disorders and heart failures.
The report "Advanced Visualization Market by Products (Hardware, Software), Services, Solution (Standalone, Enterprise), Imaging Modality (MRI, CT, PET, Ultrasound, Radiotherapy), Clinical Application (Radiology, Orthopedics, Cardiac, Neurology) - Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).The global advanced visualization market is expected to reach USD 3.19 Billion by 2021 from USD 1.89 Billion in 2016; growing at a CAGR of 11.0% from 2016 to 2021.By imaging modality, the magnetic resonance imaging segment is expected account for the largest share On the basis of imaging modality, the advanced visualization industry is segmented into magnetic resonance imaging, computed tomography, positron emission tomography, ultrasound, radiotherapy, nuclear medicine, and other imaging modalities.The magnetic resonance imaging segment is expected to dominate the advanced visualization market during the forecast period.Download a PDF Brochure @ clinical application, the hospitals, diagnostic centres, and surgical centres segment is expected account for the largest share The advanced visualization market, by clinical application, is segmented into radiology/interventional radiology, cardiology, orthopaedics, oncology, vascular, neurology, other clinical areas (includes obstetrics/gynaecology, urology, pulmonary, and gastroenterology).In 2016, the radiology/interventional radiology segment is expected to account for the largest share of the market due to the growing adoption of centralized server-based AV software, rising market preference for process automation & digitization of radiology diagnostics, and increasing adoption of AV solutions in radiology departments.North America is expected to account for the largest share of the advanced visualization industry during the forecast period The report covers the advanced visualization industry across four key geographies, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.North America is expected to dominate the global advanced visualization market in 2016.Commercialization of advanced diagnostic products, robust R infrastructure across the U.S. & Canada, and high prevalence of target diseases are the factors that drive the demand growth of advanced visualization products in the region.Request a Sample Pages @ CompaniesAs of 2015, the global advanced visualization market was dominated by General Electric Company (U.S.), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Toshiba Corporation (Japan), Terarecon, Inc. (U.S.), Fujifilm Holdings Corporation (Japan), Pro Medicus Limited (Australia), Carestream Health, Inc. (U.S.), Agfa-Geveart N.V. (Belgium), and Qi Imaging, LLC (U.S.), among others.